Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

HEPH

Hollis-Eden Pharmaceuticals (MM) (HEPH)

Hollis-Eden Pharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:HEPH
DateTimeSourceHeadlineSymbolCompany
18/02/201008:03PR Newswire (US)Hollis-Eden Announces Name Change to Harbor BioSciences, Inc. and Ticker Symbol Change to 'HRBR'NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
17/02/201008:27Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
04/02/201006:39Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
04/02/201006:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
04/02/201006:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
04/02/201006:37Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
04/02/201006:36Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
04/02/201006:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
04/02/201006:35Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
07/01/201008:31Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3/A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
23/12/200908:38Edgar (US Regulatory)Securities Registration Statement (simplified form) (S-3)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/12/200922:03Edgar (US Regulatory)Securities Registration (section 12(b)) (8-A12B)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
17/11/200901:00PR Newswire (US)Hollis-Eden Presents New Interim Data From Prostate Cancer Phase I/II Clinical Studies of Apoptone (HE3235) at AACR Molecular TaNASDAQ:HEPH
13/11/200908:37PR Newswire (US)Hollis-Eden to Present Interim Data From Its Phase I/II Clinical Studies of Apoptone(R) (HE3235) at Molecular Targets and CancerNASDAQ:HEPH
07/11/200909:23Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
22/10/200921:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
21/10/200900:11PR Newswire (US)Hollis-Eden Pharmaceuticals Retains Burrill LLC to Provide Exclusive Advisory Services for Lead ProgramsNASDAQ:HEPH
17/09/200903:33Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
16/09/200922:30PR Newswire (US)Hollis-Eden Pharmaceuticals Receives NASDAQ Notification Related to Minimum Bid PriceNASDAQ:HEPH
14/08/200920:06Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
16/06/200905:52Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
16/06/200902:30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
15/06/200921:05PR Newswire (US)Hollis-Eden Pharmaceuticals Announces Appointment of Dr. James M. Frincke President and CEONASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
12/06/200906:54Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
06/06/200906:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
14/05/200920:03Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
08/05/200907:00Edgar (US Regulatory)Proxy Statement (definitive) (DEF 14A)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
24/04/200907:00Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
01/04/200908:36Business WireHollis-Eden Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial ResultsNASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
01/04/200908:30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HEPHHollis-Eden Pharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:HEPH

Your Recent History

Delayed Upgrade Clock